ZA200304874B - Test device. - Google Patents
Test device. Download PDFInfo
- Publication number
- ZA200304874B ZA200304874B ZA200304874A ZA200304874A ZA200304874B ZA 200304874 B ZA200304874 B ZA 200304874B ZA 200304874 A ZA200304874 A ZA 200304874A ZA 200304874 A ZA200304874 A ZA 200304874A ZA 200304874 B ZA200304874 B ZA 200304874B
- Authority
- ZA
- South Africa
- Prior art keywords
- zone
- sample
- analyte
- test
- liquid
- Prior art date
Links
- 238000012360 testing method Methods 0.000 title claims description 81
- 239000007788 liquid Substances 0.000 claims description 52
- 239000012491 analyte Substances 0.000 claims description 44
- 238000006243 chemical reaction Methods 0.000 claims description 22
- 239000000463 material Substances 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 6
- 201000010099 disease Diseases 0.000 claims description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 238000001514 detection method Methods 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 208000007848 Alcoholism Diseases 0.000 claims 1
- 206010013654 Drug abuse Diseases 0.000 claims 1
- 206010001584 alcohol abuse Diseases 0.000 claims 1
- 208000025746 alcohol use disease Diseases 0.000 claims 1
- 208000011117 substance-related disease Diseases 0.000 claims 1
- 239000000126 substance Substances 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 6
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 239000011888 foil Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- -1 urine Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- SHXWCVYOXRDMCX-UHFFFAOYSA-N 3,4-methylenedioxymethamphetamine Chemical compound CNC(C)CC1=CC=C2OCOC2=C1 SHXWCVYOXRDMCX-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- GVGLGOZIDCSQPN-PVHGPHFFSA-N Heroin Chemical compound O([C@H]1[C@H](C=C[C@H]23)OC(C)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4OC(C)=O GVGLGOZIDCSQPN-PVHGPHFFSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- VAYOSLLFUXYJDT-RDTXWAMCSA-N Lysergic acid diethylamide Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N(CC)CC)C2)=C3C2=CNC3=C1 VAYOSLLFUXYJDT-RDTXWAMCSA-N 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 108010055044 Tetanus Toxin Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960003920 cocaine Drugs 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 229960002069 diamorphine Drugs 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 229950002454 lysergide Drugs 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 229940118376 tetanus toxin Drugs 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- G01N33/54387—Immunochromatographic test strips
- G01N33/54388—Immunochromatographic test strips based on lateral flow
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Analysing Materials By The Use Of Radiation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01200146 | 2001-01-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200304874B true ZA200304874B (en) | 2004-09-23 |
Family
ID=8179753
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200304874A ZA200304874B (en) | 2001-01-15 | 2003-06-23 | Test device. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20040053419A1 (ja) |
| EP (1) | EP1352244A1 (ja) |
| JP (1) | JP2004517325A (ja) |
| KR (1) | KR20030070913A (ja) |
| CN (1) | CN1639573A (ja) |
| AU (1) | AU2002225017B2 (ja) |
| BR (1) | BR0206233A (ja) |
| CA (1) | CA2433452A1 (ja) |
| MX (1) | MXPA03006284A (ja) |
| NZ (1) | NZ526754A (ja) |
| WO (1) | WO2002056019A1 (ja) |
| ZA (1) | ZA200304874B (ja) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10330982A1 (de) | 2003-07-09 | 2005-02-17 | Prisma Diagnostika Gmbh | Vorrichtung und Verfahren zur simultanen Bestimmung von Blutgruppenantigenen |
| US20080102482A1 (en) * | 2003-12-19 | 2008-05-01 | Stanley Irwin Grossman | Apparatus for Detecting Drugs in a Beverage |
| GB0405648D0 (en) | 2004-03-12 | 2004-04-21 | Bloomsbury Innovations Ltd | Apparatus |
| DE102006062619B4 (de) | 2006-12-29 | 2012-04-26 | Medion Diagnostics Ag | Verfahren zur Bestimmung von minoren Zellpopulationen in heterogenen Zellpopulationen |
| JP5247158B2 (ja) | 2008-01-16 | 2013-07-24 | パナソニック株式会社 | 試料溶液分析方法および試料溶液分析装置 |
| KR101471932B1 (ko) * | 2011-10-06 | 2014-12-11 | 주식회사 인지바이오 | 스크린 프린팅을 이용한 다중 진단 멤브레인 센서의 제조방법 |
| GB201208663D0 (en) * | 2012-05-17 | 2012-06-27 | Technostics Ltd | Saliva testing |
| US20160018424A1 (en) * | 2013-03-01 | 2016-01-21 | Compassionate Analytic Inc. | Methods for cannabinoid quantification |
| CN105445454B (zh) * | 2015-11-20 | 2016-11-30 | 广州瑞博奥生物科技有限公司 | 一种可定量的免疫层析装置 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4988627A (en) * | 1987-12-18 | 1991-01-29 | Eastman Kodak Company | Test device with dried reagent drops on inclined wall |
| DE4338811A1 (de) * | 1993-11-15 | 1995-05-18 | Boehringer Mannheim Gmbh | Verwendung von Teststreifen zur Bestimmung der UV-Intensität oder zur Vorbestimmung der sonnenbrandfreien Aufenthaltsdauer in der Sonne sowie hierfür geeignetes Testsystem und Teststreifenpackung |
| JP3334558B2 (ja) * | 1997-04-23 | 2002-10-15 | 富士レビオ株式会社 | 酵素免疫測定方法及び試験片 |
| US6436713B1 (en) * | 1997-07-28 | 2002-08-20 | 3M Innovative Properties Company | Methods and devices for measuring total polar compounds in degrading oils |
| US6194224B1 (en) * | 1998-07-27 | 2001-02-27 | Avitar, Inc. | Diagnostic membrane containing fatty acid sarcosinate surfactant for testing oral fluid |
| US6372514B1 (en) * | 1998-09-18 | 2002-04-16 | Syntron Bioresearch, Inc. | Even fluid front for liquid sample on test strip device |
| US6203757B1 (en) * | 1998-12-02 | 2001-03-20 | Bionike, Inc. | Fluid sample distriution system for test device |
| US6576193B1 (en) * | 2000-10-27 | 2003-06-10 | Shujie Cui | Device and method for collecting and testing fluid specimens |
| US7638093B2 (en) * | 2004-01-28 | 2009-12-29 | Dnt Scientific Research, Llc | Interrupted flow rapid confirmatory immunological testing device and method |
-
2002
- 2002-01-09 MX MXPA03006284A patent/MXPA03006284A/es unknown
- 2002-01-09 US US10/466,367 patent/US20040053419A1/en not_active Abandoned
- 2002-01-09 NZ NZ526754A patent/NZ526754A/en unknown
- 2002-01-09 EP EP02715445A patent/EP1352244A1/en not_active Withdrawn
- 2002-01-09 CN CNA028037030A patent/CN1639573A/zh active Pending
- 2002-01-09 JP JP2002556223A patent/JP2004517325A/ja active Pending
- 2002-01-09 KR KR10-2003-7009218A patent/KR20030070913A/ko not_active Application Discontinuation
- 2002-01-09 CA CA002433452A patent/CA2433452A1/en not_active Abandoned
- 2002-01-09 AU AU2002225017A patent/AU2002225017B2/en not_active Ceased
- 2002-01-09 WO PCT/EP2002/000437 patent/WO2002056019A1/en not_active Application Discontinuation
- 2002-01-09 BR BR0206233-0A patent/BR0206233A/pt not_active IP Right Cessation
-
2003
- 2003-06-23 ZA ZA200304874A patent/ZA200304874B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002056019A1 (en) | 2002-07-18 |
| KR20030070913A (ko) | 2003-09-02 |
| CN1639573A (zh) | 2005-07-13 |
| EP1352244A1 (en) | 2003-10-15 |
| AU2002225017B2 (en) | 2006-07-06 |
| BR0206233A (pt) | 2003-12-23 |
| JP2004517325A (ja) | 2004-06-10 |
| CA2433452A1 (en) | 2002-07-18 |
| MXPA03006284A (es) | 2003-09-16 |
| NZ526754A (en) | 2004-04-30 |
| US20040053419A1 (en) | 2004-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6514769B2 (en) | Multiple analyte assay device with sample integrity monitoring system | |
| US7547557B2 (en) | Directed-flow assay device | |
| AU669669B2 (en) | Method and device for metering of fluid samples | |
| FI96639C (fi) | Omavarainen immunokoe-elementti | |
| US6548019B1 (en) | Device and methods for single step collection and assaying of biological fluids | |
| CA2654931C (en) | Assay device and method with improved control functions | |
| US7347972B1 (en) | Multiple analyte assay device | |
| EP2284538B1 (en) | Biosensor | |
| RU2006135394A (ru) | Система из измерительного устройства уровня анализируемых веществ в биологических жидкостях и кассеты для выполнения комбинированных общих химических и специфических анализов связывания | |
| JP2003500651A (ja) | アナライト含有試料の作成方法 | |
| WO2008007359A2 (en) | Rapid diagnostic devices based on molecular imprinted polymers | |
| JP2017522573A (ja) | 側方流アッセイデバイス | |
| AU2002225017B2 (en) | Test device | |
| AU2002225017A1 (en) | Test device | |
| JP4470354B2 (ja) | １〜１００ｕｌの試料のためのインビボ検査装置 | |
| CN203561636U (zh) | 定向流免疫层析装置 | |
| JPWO2003038433A1 (ja) | 試験装置 | |
| Takahashi | Biosensor |